Literature DB >> 25893742

Paederia foetida Linn. inhibits adjuvant induced arthritis by suppression of PGE(2) and COX-2 expression via nuclear factor-κB.

Vikas Kumar1, F A Al-Abbasi, Danish Ahmed, Amita Verma, Mohd Mujeeb, Firoz Anwar.   

Abstract

The current investigation was undertaken to determine the anti-inflammatory and antioxidant effects of Paederia foetida Linn. (PF) along with its mechanism of action when implemented in tissue protection. HPTLC was used in the identification of the compound quercetin, while in vitro analysis confirmed the significance of the antioxidant and anti-inflammatory action of PF. We initially demonstrated the in vivo anti-inflammatory effect of PF, evaluating it against a variety of phlogistic agents as well as turpentine oil, prostaglandin and arachidonic acid. Groups of rats, fasted overnight, were treated as follows: Group I: normal control (vehicle), Group II: PF (100 mg kg(-1)), Group III: arthritic control (CFA only, 0.05 ml), Group IV, V, VI: CFA (0.05 ml) + PF (25, 50 and 100 mg kg(-1)) and Group VII: CFA (0.05 ml) + indomethacin (10 mg per kg b.w.). PF significantly protected against paw edema, arthritic index and body weight alteration induced by Complete Fruend's Adjuvant (CFA). Other observations, like histological and macroscopic changes, were observed in CFA induced inflammation in knee joints. Subcutaneous administration of CFA was accompanied by proinflammatory cytokine status, as appraised by the amplification of interleukin-2 (IL-2), interleukin-1β (IL-1β) and tumor necrosis factor (TNF-α); oxidative stress status was estimated by the enhancement of the level of lipid peroxidation (LPO) and the depletion of superoxide dismutase (SOD), glutathione peroxidase (GPx) and glutathione (GSH). Pre-treatment with PF significantly (P < 0.001) protected against CFA induced oxidative stress and proinflammatory cytokines. More prominently, CFA administration augmented tissue and plasma superoxide (O2) and hydrogen peroxide (H2O2) levels, while the PF pre-treatment significantly (P < 0.001) reversed all CFA induced intracellular interruption. Following CFA induced arthritis, PF was tested for its free radical scavenging activity against the DPPH and ABTS radicals and its inhibitory proficiency against COX-1 and COX-2 in vitro. Considering the above, the current research confirmed momentous protection against CFA induced arthritis, which could be attributed to its anti-inflammatory and pro-oxidant nature.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25893742     DOI: 10.1039/c5fo00178a

Source DB:  PubMed          Journal:  Food Funct        ISSN: 2042-6496            Impact factor:   5.396


  13 in total

1.  Triterpenoids principle of Wedelia calendulacea attenuated diethynitrosamine-induced hepatocellular carcinoma via down-regulating oxidative stress, inflammation and pathology via NF-kB pathway.

Authors:  Amita Verma; Deepika Singh; Firoz Anwar; Prakash Chandra Bhatt; Fahad Al-Abbasi; Vikas Kumar
Journal:  Inflammopharmacology       Date:  2017-06-12       Impact factor: 4.473

2.  The complete chloroplast genome of the medicinal plant Paederia foetida L.

Authors:  Wei Wang; Tao Xu; Xiangwen Song; Cunwu Chen; Dong Liu; Bangxing Han; Shanyong Yi
Journal:  Mitochondrial DNA B Resour       Date:  2022-07-07       Impact factor: 0.610

3.  Chemomodulatory effect Melastoma Malabathricum Linn against chemically induced renal carcinogenesis rats via attenuation of inflammation, oxidative stress, and early markers of tumor expansion.

Authors:  Amita Verma; Prakash Chandra Bhatt; Gaurav Kaithwas; Nikunj Sethi; Mohd Rashid; Yashwant Singh; Mahfoozur Rahman; Fahad Al-Abbasi; Firoz Anwar; Vikas Kumar
Journal:  Inflammopharmacology       Date:  2016-09-14       Impact factor: 4.473

4.  Nanoemulgel, an Innovative Carrier for Diflunisal Topical Delivery with Profound Anti-Inflammatory Effect: in vitro and in vivo Evaluation.

Authors:  Mehreen Bashir; Junaid Ahmad; Muhammad Asif; Salah-Ud-Din Khan; Muhammad Irfan; Asim Y Ibrahim; Sajid Asghar; Ikram Ullah Khan; Muhammad Shahid Iqbal; Abdul Haseeb; Syed Haroon Khalid; Mohammed As Abourehab
Journal:  Int J Nanomedicine       Date:  2021-02-22

5.  Fabrication, optimization, and characterization of umbelliferone β-D-galactopyranoside-loaded PLGA nanoparticles in treatment of hepatocellular carcinoma: in vitro and in vivo studies.

Authors:  Vikas Kumar; Prakash Chandra Bhatt; Mahfoozur Rahman; Gaurav Kaithwas; Hani Choudhry; Fahad A Al-Abbasi; Firoz Anwar; Amita Verma
Journal:  Int J Nanomedicine       Date:  2017-09-11

6.  Effect of Naringin on Monosodium Iodoacetate-Induced Osteoarthritis Pain in Rats.

Authors:  Qiang Xu; Zuo-Fu Zhang; Wei-Xue Sun
Journal:  Med Sci Monit       Date:  2017-08-02

7.  Protective Effect of Pinitol Against Inflammatory Mediators of Rheumatoid Arthritis via Inhibition of Protein Tyrosine Phosphatase Non-Receptor Type 22 (PTPN22).

Authors:  Kewen Zheng; Zhixuan Zhao; Na Lin; Yiyan Wu; Ying Xu; Wanli Zhang
Journal:  Med Sci Monit       Date:  2017-04-21

8.  Ursolic acid rich Ocimum sanctum L leaf extract loaded nanostructured lipid carriers ameliorate adjuvant induced arthritis in rats by inhibition of COX-1, COX-2, TNF-α and IL-1: Pharmacological and docking studies.

Authors:  Aftab Ahmad; Mohammed F Abuzinadah; Huda M Alkreathy; Babajan Banaganapalli; Mohd Mujeeb
Journal:  PLoS One       Date:  2018-03-20       Impact factor: 3.240

9.  Protective Effect of Ginkgolic Acid in Attenuating LDL Induced Inflammation Human Peripheral Blood Mononuclear Cells via Altering the NF-κB Signaling Pathway.

Authors:  Juan Zhang; Jifeng Yan
Journal:  Front Pharmacol       Date:  2019-11-08       Impact factor: 5.810

10.  Melastoma malabathricum Linn attenuates complete freund's adjuvant-induced chronic inflammation in Wistar rats via inflammation response.

Authors:  Vikas Kumar; Prakash Chandra Bhatt; Mahfoozur Rahman; Dinesh Kumar Patel; Nikunj Sethi; Atul Kumar; Nikhil Kumar Sachan; Gaurav Kaithwas; F A Al-Abbasi; Firoz Anwar; Amita Verma
Journal:  BMC Complement Altern Med       Date:  2016-12-07       Impact factor: 4.782

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.